top of page

  Your health is personal. 

So why isn't your treatment?

Your medicine dose is likely based upon your body weight or size. This century-old approach poorly considers the large variability in how individuals distribute, break-down and clear drugs from the body.

Four people of different ages and ethnicities

The impact is poor long-term quality of life associated with side-effects of critical medicine, costly management of adverse events and high-risk drug development.

Vesynta places evidence-based clinical insight in the hands of the user, ensuring tailored, safe and effective dosing for every patient.

  The patients we help

Patients groups especially disadvantaged with the ‘one size fits all’ dosing approach.​​ 

Brown-haired girl in a green t-shirt

Paediatrics (under 16 years of age)

Black-haired man in a pink shirt

Patients on dose intense regimens

An elderly man in a dark blue shirt


Little boy in a purple t-shirt

Patients with rare genetic disorders

Woman in a turquoise blouse

Small and large physiques

Red-haired young woman in a green blouse

Patients on narrow therapeutic index drugs

The value of bedside
personalised care

Earlier medicines optimisation Personalised dose modifications to safer and more effective levels,

Improving patient quality of life

Reducing adverse events and sub-optimal treatment

Ensure data quality and security

Reliable response prediction and continuous refinement 

A doctor shaking a patient's hand with his mother. A point of care drug monitoring device in the background.

Champion care standards
Focus on under-represented patients such as children

Empower patients and physicians

Full treatment ownership is provided via point-of-care access, ease of use and automation

Reduces healthare inequalities

Bedside access to high quality personal care reagardless of geographic or economic status

Interested in Vesynta?

bottom of page